COSTEM 2022 | The impact of COVID-19 vaccination in adult and pediatric patients with hematological malignancies

Simone Cesaro • 28 Oct 2022

COSTEM 2022

General

Simone Cesaro, MD, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy, comments on the benefits of COVID-19 vaccination in patients with hematological malignancies. In an observational study, mortality and ICU admission rates were reduced in immunocompromised patients who were vaccinated. In addition, Dr Cesaro discusses current guidelines on administering COVID-19 vaccines in pediatric patients and provides an overview of guidelines recommended by the Italian Pediatric Hematology Oncology Association (AIEOP) on vaccinating pediatric patients against COVID-19. By providing the latest information regarding safety and efficacy, vaccine uptake should increase among pediatric patients. This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.